Speaker's Highlight

• Don Sin University of British Columbia, St. Paul Hospital (Canada)
  Kenneth R. Chapman Toronto General Hospital Research Institute (Canada)
• Parameswaran Nair McMaster University (Canada)
  Carolyn Calfee UCSF (U.S.A.)
• Gregory P. Downey University of Colorado School of Medicine (U.S.A.)
  David A. Schwartz University of Colorado School of Medicine (U.S.A.)
• Neil Schluger Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
  Nick Kim Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
• Nicola Hananiah Baylor College of Medicine (U.S.A.)
  Jae-Joon Yim Seoul National University College of Medicine (Republic of Korea)
• Koichiro Asano Tokai University School of Medicine (Japan)
  Diahn-Warng Perng Taipei Veterans General Hospital (Taiwan)
• Konstantinos Kostikas University of Ioannina (Greece)
  Karin Klooster University Medical Center Groningen (Kingdom of the Netherlands)

• Standardizing sputum induction for tuberculosis diagnosis

  Tuberculosis diagnosis depends on obtaining a respiratory specimen that contains enough material for reliable testing. When patients cannot produce sputum spontaneously, sputum induction can improve access to lower-airway secretions and support molecular testing, smear microscopy, and culture.

  The procedure is clinically useful, but its performance varies when staff use different saline concentrations, collection times, safety precautions, or criteria for an acceptable specimen. A consistent protocol helps protect healthcare workers, reduce repeat procedures, and create results that laboratories can interpret with greater confidence.

  For respiratory medicine teams, standardization should cover the entire pathway: patient assessment, infection prevention, induction technique, specimen handling, laboratory communication, and documentation. This approach is especially relevant in settings where tuberculosis overlaps with asthma, chronic lung disease, HIV, or other causes of persistent cough.

  Why a consistent method matters

  Spontaneous sputum is generally preferred when a patient can produce it safely and adequately. However, some people have a dry cough, early disease, airway obstruction, weakness, or limited understanding of the collection process. In these cases, inhaled hypertonic saline can stimulate coughing and mobilize secretions from the lower respiratory tract.

  Variation in technique can affect diagnostic yield. A short nebulization may produce saliva rather than sputum, while poorly supervised collection can increase contamination or expose staff and other patients to infectious aerosols. Standard operating procedures make it easier to distinguish a genuinely negative result from an inadequate specimen.

  A protocol also supports equitable care. Patients should receive the same explanation, assessment, and opportunity to produce a useful sample regardless of which clinician performs the procedure or which facility provides the service.

  Preparing the patient and clinical area

  Before induction, staff should confirm the indication, review symptoms, assess the risk of bronchospasm, and explain what the patient will feel. Baseline oxygen saturation, respiratory rate, heart rate, and general clinical status should be recorded. Active severe respiratory distress, uncontrolled wheezing, or an inability to cooperate may require stabilization or an alternative sampling method.

  A bronchodilator may be considered for patients with reactive airways, according to local policy and clinical judgment. Medication history, allergies, pregnancy status, and relevant comorbidities should be reviewed. Patients should understand that the goal is to cough material from the chest into a sterile container, not simply to provide saliva.

  The collection area should support airborne infection control. Ideally, induction occurs in a negative-pressure room or another appropriately ventilated space away from crowded waiting areas. Staff need fit-tested particulate respirators, eye protection, gloves, and gowns when indicated. The patient should wear a medical mask before and after the procedure and remove it only for nebulization and expectoration.

  A reproducible induction protocol

  Protocols commonly use sterile normal saline followed by hypertonic saline, often 3%, 5%, or 7%, delivered through a suitable nebulizer. The selected concentration, treatment duration, and escalation plan should be defined locally rather than left to individual preference. Bronchodilator pretreatment can reduce bronchospasm risk in selected patients.

  The patient should sit upright and receive clear coaching on relaxed breathing, periodic deep breaths, and forceful coughing from the chest. Staff should monitor symptoms and vital signs throughout the procedure. If wheezing, marked breathlessness, chest tightness, oxygen desaturation, or clinical deterioration develops, induction must stop and the patient should receive appropriate assessment.

  An adequate sample is usually visibly mucoid or mucopurulent rather than clear, watery saliva. If the first attempt is insufficient, the protocol should specify whether to continue nebulization, provide additional coaching, or arrange another sampling strategy. The number of attempts and stopping rules should be documented consistently.

  Protocol element	Standardized approach	Why it matters
  Patient assessment	Record indication, respiratory status, contraindications, and baseline observations	Identifies patients who need stabilization or an alternative
  Nebulized solution	Use a defined saline concentration and equipment type	Reduces variation in airway stimulation
  Clinical monitoring	Observe symptoms, oxygen saturation, and response throughout	Allows early recognition of bronchospasm or deterioration
  Specimen quality	Prefer lower-airway material over clear saliva	Improves the chance of detecting Mycobacterium tuberculosis
  Infection control	Use appropriate ventilation, respirators, and controlled collection	Limits aerosol exposure and cross-infection
  Transport	Label, seal, and send promptly according to laboratory policy	Protects specimen integrity and traceability

  Protecting specimen quality and laboratory safety

  Collection containers should be sterile, leak-resistant, clearly labeled, and opened only when the patient is ready to expectorate. Staff should avoid transferring material between containers unnecessarily. The request form should state that the specimen was induced and include relevant clinical information, such as suspected pulmonary tuberculosis, previous treatment, HIV status when appropriate, and current symptoms.

  Prompt transport is important because delays, heat, leakage, or incorrect storage can compromise testing. Laboratories should receive specimens through a defined chain of custody, with clear procedures for rejecting unsuitable containers or resolving incomplete labels. Molecular assays such as Xpert MTB/RIF or Xpert Ultra can provide rapid evidence of tuberculosis and rifampicin resistance, but they do not eliminate the value of culture and drug susceptibility testing when indicated.

  A poor-quality sample should not automatically be recorded as a true negative. Laboratory and clinical teams should communicate when the specimen contains mostly saliva, when the volume is inadequate, or when repeat collection is necessary. This distinction can prevent false reassurance and delayed treatment.

  Integrating induction into respiratory care

  Sputum induction should sit within a broader diagnostic pathway rather than operate as an isolated procedure. Chest imaging, symptom duration, exposure history, HIV testing where appropriate, and assessment for extrapulmonary disease all influence the interpretation of a respiratory specimen. Children, critically ill patients, and people unable to cooperate may need gastric aspirates, nasopharyngeal approaches, bronchoscopy, or other locally validated alternatives.

  Coexisting airway disease can complicate both the decision to induce sputum and the interpretation of symptoms. Teams working across respiratory specialties may also encounter patients receiving long-term therapies for other conditions; guidance on macrolide therapy illustrates why medication history and differential diagnosis should remain part of a careful pulmonary assessment.

  A standardized pathway should also define when presumptive tuberculosis treatment, isolation, referral, or urgent specialist review is required. The procedure supports diagnosis, but it must not delay clinical action in a patient who is seriously ill or highly infectious.

  Practical safeguards for implementation

  A reliable program depends on training, supervision, and periodic review. Staff should demonstrate competence in patient coaching, nebulizer use, personal protective equipment, emergency response, specimen labeling, and waste disposal. Competency checks can be repeated after equipment changes, protocol revisions, or an adverse event.

  Facilities should monitor both technical and clinical indicators. Useful measures include the proportion of induced samples meeting quality criteria, time from collection to testing, frequency of repeat procedures, adverse events, contamination rates, and the percentage of positive molecular results followed by appropriate clinical management.

  Core safeguards include:

  • Use a written protocol with defined saline concentrations, treatment times, stopping rules, and escalation procedures.
  • Perform induction only in a suitable, well-ventilated or negative-pressure environment with trained staff.
  • Record specimen appearance, volume, collection method, patient tolerance, and any interruption or adverse event.
  • Coordinate closely with the laboratory on packaging, transport, testing priorities, and rejection criteria.
  • Review diagnostic yield and safety data regularly, then update training and equipment requirements.

  Standardization is most effective when clinicians, nurses, infection-control teams, laboratory scientists, and public health services share responsibility for the pathway. A conference community focused on respiratory medicine can help align these groups around practical protocols that are safe, reproducible, and adaptable to local resources.

  Use these principles to review your tuberculosis sampling workflow, identify variation between teams, and establish a documented induction pathway that every trained staff member can follow. Consistent collection strengthens laboratory results and supports faster, safer decisions for patients and the communities they may affect.

  Richard Russell Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
• Mona Bafadhel King’s College London (United Kingdom)
  David Jackson Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
• James Chalmers University of Dundee (United Kingdom)
  David Price University of Aberdeen (United Kingdom)